Mouse fibroblast cell lines were transfected with truncated forms of the human poliovirus receptor (PVR) cDNA and tested for the expression of functional receptors for poliovirus. Several receptor constructs, all containing the coding region of the first 143 amino acids of PVR, were able to render mouse cells susceptible to poliovirus infection. A deletion of 65 amino acids in the first extracellular domain of PVR prevented virus attachment and infection. These data suggest that domain 1 is necessary and sufficient for the virus-receptor interaction. A PVR/intercellular adhesion molecule 1 hybrid receptor, expressing the PVR variable domain on a truncated receptor molecule for human rhinovirus 14, was shown to be a functional receptor for poliovirus. This observation indicates that, subsequent to attachment to the PVR-binding domain, poliovirus can use the same pathway as the major receptor group rhinoviruses to enter cells.
The cellular receptor for poliovirus (PVR) has recently been identified as a protein belonging to the immunoglobulin supergene family (1, 2) . The sequence of cDNA encoding PVR revealed a polypeptide with a predicted molecular mass of 46 kDa prior to glycosylation. This polypeptide consists of three extracellular domains characteristic for certain immunoglobulin-like proteins (3) in the order V-C2-C2 (where V = variable and C = constant) that are followed by a hydrophobic membrane-spanning segment and a C-terminal tail ( Fig. 1 ; PVR dl + 2 + 3). The extracellular portion ofthe PVR carries eight potential N-glycosylation sites (see Fig. 2 ), and, indeed, the protein migrates as a 67-kDa polypeptide when HeLa cell membranes are subjected to Western blot analyses (4) or when PVR-specific cDNA is expressed in vivo by means of a vaccinia virus vector (4) or in a baculovirus expression system (5) and in vitro by translation in a rabbit reticulocyte extract in the presence of dog pancreas microsomes (4) . The molecular parameters of the interaction between poliovirus and its receptor, however, have not been elucidated.
Poliovirus is a small RNA virus belonging to the genus Enterovirus of the family Picornaviridae. Another genus of this family is Rhinovirus, which encompasses two groups: the minor receptor group and the major receptor group rhinoviruses, of which the latter represents >80% of all known rhinoviruses (6, 7) . Although entero-and rhinoviruses are very closely related with respect to their structure (8) and molecular biology (9) , they use a variety of receptors most of which remain unknown (reviewed in ref. 10 ). However, the receptor for the major group rhinoviruses has recently been identified to be intercellular adhesion molecule 1 (ICAM-1) (11) (12) (13) . Like PVR, it is a protein of the immunoglobulin supergene family, but it differs from PVR in that ICAM-1 consists of five C2-like folds (Fig. 1 ).
The pathway of penetration and uncoating of all picornaviruses is poorly understood. Evidence has been presented suggesting that after poliovirus and rhinovirus attach to their respective receptors, the particles enter host cells by means of endocytosis (reviewed in ref. 14) . However, the requirement of low pH for uncoating of poliovirus has recently been called into question (15) . Moreover, it is not known whether the pathway of uptake for poliovirus and for the major group rhinoviruses is the same.
Mouse cells can be rendered sensitive to poliovirus infection by transfection of human DNA into mouse cell lines (16) or into the mouse genome (17, 18 To generate pPVRdl/IC, we amplified a DNA fragment of plasmid pHRR19 (an ICAM-1 cDNA clone given to us by A. McClelland) by using the polymerase chain reaction with the oligodeoxynucleotide primers 5'-CCGGCTAGCTGTCCT-GCCAGCGACTCCCCC-3' and 5'-GGCGCGGATC-CCCCGGGATAGGTTCAGGGAGG-3'. The 30-mer generates an Nhe I restriction site (underlined) just 5' to sequences encoding the ICAM-1 extracellular domains 3-5; the other primer generates a BamHI site after the ICAM-1 coding sequence. Polymerase chain reaction was performed for 25 cycles with a DNA amplification kit (Perkin-Elmer/Cetus). The polymerase chain product was treated with the Klenow fragment of E. coli DNA polymerase I, incubated with the restriction enzymes Nhe I and BamHI, and purified by gel electrophoresis. The 960-bp Nhe I-BamHI fragment was ligated into plasmid pTMPVR, which contains a silent mutation harboring a restriction site for Nhe I (nt 663), replacing the 804-bp Nhe I-BamHI fragment of the PVR sequence to create pPVRdl/IC.
Cell Lines and Transfections. Mouse MOP8 and OST7-1 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) with 8% calf serum. G418 (GIBCO; 400 ,ug/ml) was added in cultures of OST7-1 cells.
DNA transfections into MOP8 and OST7-1 cell lines were performed by electroporation in a BRL Cell-Porator (Bethesda Research Laboratories). Cells in the exponential phase of growth were trypsinized, washed, and resuspended in serum-free DMEM at a concentration ofabout 1 x 107 cells per ml; 3 1Lg of expression plasmids was included in this medium. Following electroporation (260-280 V; 800 tkF) and a 10-min recovery period, cells from a single cuvette were split into two or three equal portions and plated in DMEM containing 8% calf serum. After 15-24 hr in culture the cells were used in binding and infectivity assays.
Labeling of Poliovirus and Antibodies for Binding Assays. cpm per plate) to monolayer cells was performed at 4°C for 2 hr. Cells were washed and lysed as described above. Infectivity Assay. Mouse cells transfected with different PVR constructs were infected with PV1(M) 12-15 hr after transfection. Twenty plaque-forming units per cell were adsorbed at room temperature for 30 min, and cells were washed and incubated in DMEM/8% calf serum at 37°C. At the appropriate time points, medium was aspirated and cells were scraped off the plates and resuspended in 2 ml of phosphate-buffered saline. Virus was recovered from the cell suspension by freeze-thawing and titered by plaque assays on HeLa monolayer cells as described (22) .
RESULTS
Binding Properties ofPVR Deletion Mutants. Modified PVR molecules were constructed as indicated in Fig. 2 and inserted into mammalian expression vectors in which the gene is transcribed under the control of the AdMLP or T7 promoters and translated under the control of the 5' nontranslated region (5' NTR) of encephalomyocarditis virus (EMCV) RNA (23) . In addition, we also cloned the origin ofreplication of polyoma virus into pMT2-derived plasmids to facilitate replication in MOP8 cells, a mouse fibroblast cell line stably expressing polyoma large tumor antigen (24) . In each of the vectors, the PVR-specific extracellular domains were joined (Fig. 4) . In a single-step growth curve, the yield ofinfectious virus from mouse cells expressing the complete PVR (dl + 2 + 3) or the receptor with the first two domains ofPVR (dl + 2) was almost identical. Therefore, deletion of domain 3 does not severely affect receptor function. Virus titers measured just after infection (0 hr) reflected the different binding properties of the recombinant receptors (see Fig. 3 ). A PVR/ICAM-1 Hybrid Molecule Confers Poliovirus Susceptibility to Mouse Cells. The low efficiency with which the V domain alone ( Fig. 1; dl) functions as a receptor may have a variety of reasons, of which one could simply be spacing of the virus-binding site from the cell surface. Thus, removal of the two downstream C2 regions in PVR may prevent accessibility and/or exposure of the virus-binding V domain and could also interfere with proper folding of the V domain. Moreover, the dl variant contained amino acid sequences (residues 143-162) that we have preliminarily assigned as belonging to the /3 strand A of domain 2 (Fig. 2) . To test whether these domain 2-specific amino acids and/or spacing play a role in virus binding, we fused the 143 amino acids of the PVR V domain onto a truncated molecule of ICAM-1 giving rise to a polypeptide denoted dl/IC. Specifically, this construct encodes, in addition to the PVR V domain, three C2-like domains, the transmembrane domain, and the cytoplasmic region of ICAM-1. For expression of this construct we used the vector pTM1, in which transcription is controlled by the phage T7 promoter, and translation is controlled by the EMCV 5' NTR (Fig. SA) . When such a vector is transfected into mouse cells, which constitutively express cytoplasmic T7 RNA polymerase (OST7-1 cells; ref. 38) , synthesis of the gene product can be detected within 8 hr after transfection A Deletion in the V Domain Abolishes Poliovirus Binding. A PVR variant with a partially deleted V domain was constructed by removing an Aat II-EcoRI fragment from the coding region of the cDNA (Fig. 2) . The resulting mutant, PVRAE, which had a deletion of 65 amino acids in the N-terminal portion of the V domain, was unable to bind significantly poliovirus or monoclonal antibody D171 when expressed in OST7-1 cells (Fig. 5B) . Accordingly, it also failed to render the OST7-1 cells sensitive to poliovirus infection (Fig. 5C ).
DISCUSSION
Different viruses have adopted various cell surface molecules as the receptor by which their entry into host cells is mediated. This process of adoption seems to have occurred randomly, as virus receptors differ widely in their chemical properties. For example, the receptor for influenza virus is sialic acid, a simple carbohydrate, whereas the receptor for human immunodeficiency virus is CD4, a complex polypeptide (see ref. 14) . Members of the same virus family can use very different receptors, and picornaviruses exemplify this phenomenon (10) . Similarities in virion structure may have directed some picornaviruses to cell surface entities that appear to be related; however, subtle structural differences may result in other picornaviruses interacting with quite unrelated receptors. The particles of poliovirus, an enterovirus, and human rhinovirus 14 (HRV14), a rhinovirus, form pronounced "valleys" and "canyons" (26, 27 ) that surround the apex at the five-fold axis. For rhinovirus 14 it has been fairly well established that these canyon structures harbor the sites of receptor attachment (28, 29) . Based on the similarity of the virion structures and the host cell receptors it is highly likely that poliovirus also uses these canyons as receptorbinding sites. As proposed by the "canyon hypothesis" (30) , these deep canyon structures are inaccessible to antibodies, whereas narrower receptor domains can enter and interact with specific binding sites. It may not only be coincidence, then, that these viruses adopted monomeric immunoglobulinlike structures (PVR and ICAM-1) as receptors, and one may speculate that the receptor for enteroviruses of the coxsackie B type (31) , has immunoglobulin-like structure also. In contrast, foot-and-mouth disease virus (a member of the genus Aphthovirus of the family Picornaviridae) lacks a canyon (32) . Instead, the viral attachment site is probably within a pronounced surface loop, and the Aphthovirus receptor is likely to belong to the integrin supergene family (33) .
Based on these considerations, it may not be surprising that the data presented here reveal similarities between the A Pv I (M) D171 .1. r----i r--,-l uptake of poliovirus and HRV14. We have shown that the PVR V domain serves as the attachment site for poliovirus, just as the N-terminal C2 domain of ICAM-1 is the major point of contact in the HRV14-receptor interaction (28, 29, 34, 35) . In an analogous manner to these picornavirus receptors, the N-terminal V domain of the immunoglobulin-like CD4 receptor interacts with the human immunodeficiency virus envelope protein gp120 (36, 37) . Thus, in addition to virion structure, parameters such as accessibility may have influenced the choice of domains in immunoglobulin-like molecules for the binding of the virion.
It is possible that PVR docks into poliovirus in a similar way as ICAM-1 does into rhinovirus (35) . However, the PVR V domain with its two additional f3 strands may require more space than C-like domains and its orientation within the canyon may differ from the ICAM-1-rhinovirus interaction. Molecular modeling of the V domain of PVR has allowed us to "dock" this domain into the canyon of poliovirus (M. deCrombrugghe, D. Oren, J. Harber, E. Arnold, and E.W., unpublished data), but the precise nature and position of amino acids that form the points of contact between these structures remain to be determined. Our data clearly indicate that the V domain of PVR alone is competent to serve as receptor. Binding of virus particles by the V domain, however, is not efficient, and a second domain augments the interaction. Expression of the N-terminal C2 domain of ICAM-1 has not been reported so far. It thus remains unknown whether a single domain of ICAM-1 alone is competent as a receptor for rhinovirus.
The pathway by which entero-and rhinoviruses enter the cell and uncoat is not well understood but most likely involves endocytosis (for further references, see ref. 14). Clearly, PVR and ICAM-1 must ultimately facilitate passage of the viral RNA through the plasma cell membrane. Interestingly, ICAM-1 is involved in intercellular communication and adhesion, and receptor activity for transport of ligands into the cell is not necessarily a property of intercellular attachment proteins. Nevertheless, ICAM-1 mediates transport of HRV14 into cells, and we have shown here that the uptake of poliovirus into mammalian cells can be facilitated even by a truncated ICAM-1 molecule. This chimeric molecule was functional, although the sequence of ICAM-1 differs significantly from that of PVR, including the C-terminal, cytoplasmic tail. Thus, the V domain of PVR, either alone or in cooperation with several V domains bound to the virus, can confer destabilization (and uncoating) of poliovirions even when presented on a heterologous backbone. We consider it possible that the V domain of PVR can function as PVR when attached to immunoglobulin-like molecules other than ICAM-1, as, for example, CD4.
Note Added in Proof. Similar results confirming that the poliovirusbinding site resides in domain 1 in PVR were obtained by Koike et al. (39) .
